Related Experiment Video
Updated: Jun 3, 2026

09:00
A Multi-detection Assay for Malaria Transmitting Mosquitoes
Published on: February 28, 2015
Microtiter Array Diagonal Gel Electrophoresis (MADGE) for Population Scale Genotype Analyses.
1Division of Cardiovascular Genetics, Department of Medicine, University College London Medical School, London, UK.
Methods in Molecular Medicine
|March 5, 2011
Summary
Genetic diagnostics are primarily used for single-gene disorders. Population screening for common diseases faces challenges due to high costs and logistical complexities, limiting large-scale genetic epidemiology research.
Area of Science:
- Genetics
- Epidemiology
- Medical Diagnostics
Background:
- Human populations exhibit significant genetic variation, influencing both physical traits and disease susceptibility.
- Current genetic diagnostics focus on individual or family-based testing for single-gene disorders.
- Population screening for conditions like cystic fibrosis remains in feasibility study stages.
Purpose of the Study:
- To evaluate the feasibility of population-level genetic screening for common complex diseases.
- To identify challenges hindering large-scale genetic epidemiology research.
- To discuss the implications of genetic variation for public health.
Main Methods:
- Review of existing criteria for population screening (Wilson and Jungner).
- Analysis of cost and logistical factors associated with genetic testing and sample collection.
- Examination of research methodologies for genetic associations in common diseases.
Main Results:
- Genetic diagnostic applications are predominantly for single-gene disorders, not population screening.
- High costs of genetic tests and complex logistics (consent, data collection) impede population screening.
- Research on genetic associations for common diseases (e.g., cardiovascular disease, Alzheimer's) is often limited to small study groups.
Conclusions:
- Population screening for genetic predispositions to common diseases faces significant feasibility hurdles.
- Economic and logistical barriers currently limit widespread application of genetic screening in epidemiology.
- Further advancements in cost-effectiveness and methodology are needed for large-scale genetic population studies.

